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56Treatment of acute visceral aortic pathology with
fenestrated/branched endovascular repair in
high-surgical-risk patients
Salvatore T. Scali, MD,a Alyson Waterman, MD,a Robert J. Feezor, MD,a Tomas D. Martin, MD,b
Philip J. Hess Jr, MD,b Thomas S. Huber, MD, PhD,a and Adam W. Beck, MD,a Gainesville, Fla
Objective: The safety and feasibility of fenestrated/branched endovascular repair of acute visceral aortic disease in high-
risk patients is unknown. The purpose of this report is to describe our experience with surgeon-modiﬁed endovascular
aneurysm repair (sm-EVAR) for the urgent or emergent treatment of pathology involving the branched segment of the
aorta in patients deemed to have prohibitively high medical and/or anatomic risk for open repair.
Methods: A retrospective review was performed on all patients treated with sm-EVAR for acute indications. Planning was
based on three-dimensional computed tomographic angiogram reconstructions and graft conﬁgurations included various
combinations of branch, fenestration, or scallop modiﬁcations.
Results: Sixteen patients (mean age [6 standard deviation], 68 610 years; 88% male) deemed high risk for open repair
underwent urgent or emergent repair using sm-EVAR. Indications included degenerative suprarenal or thor-
acoabdominal aneurysm (six), presumed or known mycotic aneurysm (four), anastomotic pseudoaneurysm (three), false
lumen rupture of type B dissection (two), and penetrating aortic ulceration (one). Nine (56%) had previous aortic surgery
and all patients were either American Society of Anesthesiologists class IV (n[ 9) or IV-E (n[ 7). A total of 40 visceral
vessels (celiac, 10; superior mesenteric artery, 10; right renal artery, 10; left renal artery, 10) were revascularized with
a combination of fenestrations (33), directional graft branches (six), and graft scallops (one). Technical success was 94%
(n[ 15/16), with one open conversion. Median contrast use was 126 mL (range, 41-245) and ﬂuoroscopy time was 70
minutes (range, 18-200). Endoleaks were identiﬁed intraoperatively in four patients (type II, n[ 3; type IV, n[ 1), but
none have required remediation. Mean length of stay was 12 6 15 days (median, 5.5; range, 3-59). Single complications
occurred in ﬁve (31%) patients as follows: brachial sheath hematoma (one), stroke (one), ileus (one), respiratory failure
(one), and renal failure (one). An additional patient experienced multiple complications including spinal cord ischemia
(one) and multiorgan failure resulting in death (n [ 1; in-hospital mortality, 6.3%). The majority of patients were
discharged to home (63%; n[ 10) or short-term rehabilitation units (25%; n[ 4), while one patient required admission
to a long-term acute care setting. There were no reinterventions at a median follow-up of 6.2 (range, 1-16.1) months.
Postoperative computed tomographic angiogram was available for all patients and demonstrated 100% branch vessel
patency, with one type III endoleak pending intervention. There were two late deaths at 1.4 and 13.4 months due to
nonaortic-related pathology.
Conclusions: Urgent or emergent treatment of acute pathology involving the visceral aortic segment with fenestrated/
branched endograft repair is feasible and safe in selected high-risk patients; however, the durability of these repairs is yet
to be determined. (J Vasc Surg 2013;58:56-65.)Despite the evolution of aortic stent graft design, 30%-
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Good-risk patients may tolerate elective, open repair of
complex aneurysmal disease extending into the visceral aorta;
however, patients with poor cardiac, pulmonary, and/or renal
function have>40%-70%morbidity and 40%-60% periopera-
tive mortality in the emergent setting.3-8 Although signiﬁcant
advancements in anesthetic care, operative technique, and
postoperative management have occurred, these results have
not substantially changed over the past 3 decades.8,9
Outcomes for thoracoabdominal aortic aneurysm
(TAAA) repair are largely determined by the clinical presenta-
tion, with procedures performed emergently being highly
correlated with perioperative mortality.3,10-12 The use of
“chimney,” “snorkel,” and “periscope” techniques, as well
as fenestrated and branched endografts has greatly broadened
the management options for patients with aortic disease
extending to the visceral segment.2,13-16 As evidenced by
the growing body of literature, the use of these techniques is
becoming increasingly common, with promising outcomes
being reported for patients with highly lethal conditions.17-20
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customized devices for the visceral aorta, but these require
weeks to months to manufacture and, thus, cannot be
used in the emergent setting. Moreover, devices designed
for “off-the-shelf” use are also being developed and
currently entering clinical trials but are likely many years
from widespread availability.21,22 Because of these limita-
tions, surgeons have used device modiﬁcation to facilitate
treatment of patients who are deemed to be prohibitively
high risk for open repair.23 The application of these tech-
niques in the urgent or emergent setting remains unproven
and poorly represented in the current literature.
This study was performed to determine our outcomes
with surgeon-modiﬁed, fenestrated, and branched surgeon-
modiﬁed endovascular aneurysm repair (sm-EVAR) devices
in high-risk patients with acute visceral aortic disease.
METHODS
Subjects and database. A retrospective review of our
endovascular aortic registry was queried for patients treated
with acute pathology approximating or involving the
visceral segment of the aorta. Patients treated with sm-
EVAR were identiﬁed and those treated with “chimney”
stents or debranching procedures were excluded. Between
January 2010 and July 2012, 16 patients were identiﬁed.
Indications included symptomatic or ruptured presenta-
tions of the following pathologies: TAAA, anastomotic
pseudoaneurysm, dissection-related and mycotic aneurysm,
as well as penetrating aortic ulceration. Urgent patients
were categorized by presence of symptoms deﬁned by
a presentation of abdominal, ﬂank, and/or back pain that
was not attributable to a nonaortic pathology. Emergent
presentations were deﬁned by evidence of radiographic
rupture and/or hemodynamic lability. This study was
approved by the University of Florida Institutional Review
Board (#161-2012).
All subjects were initially considered for open repair
but subsequently judged to be prohibitively high risk due
to the predicted likelihood of experiencing profound
morbidity or death with open repair based on a combination
of medical comorbidities24-26 and/or anatomic complexity.
Although individualized to each scenario, high-risk anatomic
criteria generally included acute complicated dissections,
visceral patch pseudoaneurysms, and mycotic aneurysms.
Medical high risk was deﬁned as patients anticipated being
unable to tolerate aortic cross-clamping or open thoracotomy
(because of a combination of multiple advanced medical
comorbidities). Signiﬁcant medical comorbidities were
deﬁned based on the Society for Vascular Surgery (SVS)
reporting guidelines.26
Because of the unique constellation of medical and
anatomic factors that deﬁned high risk for each patient,
there was consensus opinion obtained regarding risk for
open repair in each case among the members of the group
(Vascular Surgery and/or Cardiovascular Surgery) that
open repair was prohibitively high risk. Patients were antic-
ipated to have a reasonable probability of successful endo-
vascular repair, and the patients and/or their families werethoroughly informed of the “off-label” nature of this type
of repair.
Patient records were reviewed to obtain demographic
and medical history, as well as details of case conduct and
technical outcome. Preoperative computed tomographic
angiograms (CTAs) were reviewed to evaluate aortic
anatomy. Although a variety of aortic pathologies were
treated, lesion extent was categorized into the Crawford
classiﬁcation according to the reporting standards for
thoracic endovascular aortic repair (TEVAR)27 in an effort
to further highlight the magnitude of the type of open
surgical reconstruction that would be required if not
completed with endovascular repair, as well as to risk-
stratify patients for spinal cord ischemia events related to
the boundaries of the aortic treatment zones. Patient
records were reviewed to capture periprocedural morbidity.
Preoperative SVS comorbidity risk scores were calculated in
a manner previously reported ($8 considered high medical
risk).26,28 The Social Security Death Master File was
queried to determine survival.
Preoperative planning and operative technique. All
patients were able to be hemodynamically stabilized at
presentation and admitted to the intensive care unit for
resuscitation and patient/family counseling prior to opera-
tive intervention. Those with contained rupture were
managed with permissive hypotension with a goal mean
pressure above 50 mm Hg, similar to reported descriptions
of ruptured aneurysm management.29 When time allowed,
prophylactic spinal drains were placed selectively based on
described guidelines from our group30 and surgeon pref-
erence. Subjects were treated using modiﬁed Cook (Cook
Medical, Inc, Bloomington, Ind) endografts and custom-
ized in the operating room using plans based on a preop-
erative three-dimensional reconstruction of axial imaging
(TeraRecon Inc, San Mateo, Calif).
All patients remained hemodynamically stable during
induction, and anesthetic preparation was performed
concomitantly with graft modiﬁcation. A two-team
approach was used to achieve vascular access while the graft
was prepared. Patients were repaired with a variety of
endograft conﬁgurations including fenestrated/branched
“composite” grafts (nonmodiﬁed Endologix Powerlink at
the bifurcation with a surgeon-modiﬁed Cook TX2 proxi-
mally, n ¼ 1), modiﬁed bifurcated grafts (n ¼ 1), and
fenestrated/branched tube grafts (n ¼ 14) with or without
a distal bifurcated Cook Zenith device (Fig 1).
This report is not intended to be a technical description
of how to perform graft modiﬁcation, and each graft was
highly customized to the patient’s anatomy, so a detailed
narrative of each case is beyond the scope and purpose of
this analysis. However, various methods of modiﬁcation
were employed to accommodate individual anatomy,
including combinations of scallops, fenestrations, and
directional graft branches (Fig 1). As a general rule, fenes-
trations and scallops were placed in segments of the device
that would approximate the aortic wall diameter with full
main body deployment, and branches were used when
the target vessel was in an aneurysmal segment of the aorta.
Fig 1. This image demonstrates a graft used for repair of a suprarenal aneurysm. The graft was modiﬁed with two
fenestrations (white arrows) for the celiac and superior mesenteric arteries and two straight graft branches (black arrows)
for the renal arteries. Note the fenestration conﬁguration with a polytetraﬂuoroethylene grommet (Atrium Advanta
SST graft) sewn together with a radiographic marker around the perimeter of the fenestration using a Gore suture. The
straight graft branches are w3-mm-long branches created from a 7-mm Gore Viabahn stent graft and sewn in place
with a Gore suture incorporating the base of the branch along with a radiographic marker. Also note the temporary
diameter-reducing sutures located at each stent ring, which allows ﬂow through and around the graft during branch
vessel catheterization. The image on the right is a postoperative three-dimensional reconstruction, where the lower
portion of the graft (pie symbol) is an unmodiﬁed Endologix Powerlink device and the upper portion is a modiﬁed Cook
Zenith TX2 graft (asterick portion) with four fenestrations, each revascularized with Atrium iCast stent grafts.
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grafts. The single scallop in this series was made at the distal
aspect of a TX2 graft, and was 12 mm in depth and 15 mm
wide. Fenestrations were reinforced with a thin (w1 mm)
polytetraﬂuoroethylene cuff created from a 6- or 7-mm
Atrium SST bypass graft (Atrium USA, Hudson, NH)
and sewn in place with a CV6 Gore suture (W. L. Gore
& Associates, Newark, Del) along with a radiographic
marker created from the end of a 0.014-inch Boston
Scientiﬁc Thruway wire (Boston Scientiﬁc, Natick, Mass).
Directional graft branches were made with their orientation
in-line with the direction of the target branch vessel
(straight or downward orientations). They were created
using a portion of a 6-8 mm Gore Viabahn stent graft
(W. L. Gore & Associates) (based on the target vessel
diameter). Downward branches were secured with a CV6
Gore suture (W. L. Gore & Associates) with a radiographicmarker at the base and were oriented such that they would
approximate the orientation of the target vessel. Straight
branches were typically w3 mm length and placed directly
over the site of the target vessel.
Temporary diameter-reducing sutures were placed to
allow perfusion through and around the graft into the
branch vessels during catheterization. This was achieved
using a combined method of a posterior diameter-
reducing wire (similar to that described by Oderich31)
proximally and circumferential diameter reduction distally
using 5-0 chromic sutures. The proximal sutures were
deployed by wire removal, and the distal sutures were
opened using a compliant balloon (Cook CODA [Cook
Medical] or Medtronic Reliant [Medtronic, Inc, Minneap-
olis, Minn]), prior to deployment of the stent grafts used
for branch vessel revascularization (Fig 2). Using both
the wire-released diameter reduction proximally and the
Fig 2. The left image demonstrates a Gore TAG sheath with multiple smaller sheaths placed through the hub of the
device for revascularization of four branch vessels. The image on the right demonstrates an endograft within an Extent
IV thoracoabdominal aortic aneurysm (TAAA) with four target vessels catheterized.
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ment of the endografts to ensure successful branch-vessel
revascularization. Cook Zenith infrarenal endografts were
also modiﬁed in some patients, with posterior diameter
reduction achieved using the top cap wire passed through
and through the graft in a similar manner as described
above.
The procedures were performed in a hybrid operating
room, and the technique for deployment depended on
the strategy of branch vessel revascularization that was
employed. For grafts with downward branches, the
vessels were revascularized from brachial or axillary access
and generally revascularized one at a time. For fenestra-
tions and straight branches, revascularization was per-
formed via femoral access, and typically access to all of
the branch vessels was achieved prior to full graft
deployment.
In this series of patients (n ¼ 15/16), the majority
of femoral access was obtained percutaneously using
a “Preclose” technique as described previously.32 In
selected cases, iliac angioplasty and stent graft placement
were used to create an endovascular conduit to facilitate
device entry based on a previously published report.33
Branch vessel location was noted with intravascular ultra-
sound and/or aortography. After unsheathing the device,
access to the inner portion of the graft was usually obtained
from the contralateral femoral artery. In some cases, ipsilat-
eral access was obtained after deployment of the proximal
portion of the endograft and removal of the delivery
system. In either case, in the event that branches were
revascularized from the femoral access, a Gore TAG sheath
(W. L. Gore & Associates) (20 or 22F) was placed within
the body of the endograft and used to allow branch vessel
access with multiple smaller sheaths (Fig 2).
The preferred visceral branch stent grafts were Atrium
iCAST (Atrium Medical Corporation, Hudson, NH).
Stent graft length varied and depended on whether the
endograft was directly opposed to the aortic wall or not.
Stent grafts through fenestrations were deployed such
that 3-4 mm remained within the lumen of the endograft.The portion of the stent graft within the target vessel was
dilated to the vessel size, and the portion within the aortic
lumen was ﬂared using a 10- or 12-mm balloon.
Technical success was deﬁned as successful graft
deployment into the intended aortic segment(s), with
revascularization of all visceral branch vessels, no evidence
of extra-anatomic contrast extravasation, and absence of
type I or III endoleak at case completion.
Surveillance protocol. All patients underwent an
in-hospital CTA postoperatively with images obtained in
2-mm increments (including a noncontrasted, arterial-
phase and delayed venous phase) and then followed with
a CTA performed using the same protocol at 1 month. If
the patients had no renal dysfunction, follow-up CTAs
were performed with the same imaging protocol at 6
months, 12 months, and annually thereafter. In the case
of nondialysis-dependent renal dysfunction (estimated
glomerular ﬁltration rate <30 mL/min/1.73m2), a non-
contrasted CT was performed and supplemented with
visceral/renal duplex. CTA was only performed in these
patients if aneurysm growth or ﬁndings on duplex war-
ranted. Reintervention was deﬁned as any secondary
procedure that was performed to treat the initial intended
aortic pathology or procedure-/device-related complica-
tions and required a return trip to the operating room.
Statistical analysis. All statistical analyses were per-
formed using Stata software (v. 9.2; Stata Corp, College
Station, Tex). Categorical factors were summarized using
frequencies and percentages, whereas continuous variables
were described using means, medians, and standard devia-
tions. Categorical variables and continuous measures were
compared between groups using Fischer exact test or
two-sampled t-tests when indicated. Overall patient
survival was estimated using Kaplan-Meier methodology. A
signiﬁcance level of 0.05 was assumed for all tests.
RESULTS
Subjects and preoperative characteristics. Between
January 2010 and June 2012, 236 patients underwent
TEVAR and 125 patients underwent EVAR at the
Table I. Patient demographics, comorbidities, and
preoperative medical therapy history
Demographics N ¼ 16
Age (6 SD), years 68 6 10
Sex (male) 14
Comorbidities
Hypertension 15
Smoking/COPD 11
Dyslipidemia 10
Coronary artery disease 6
Chronic renal insufﬁciencya 4
Diabetes 3
Cerebrovascular disease 3
Congestive heart failure, EF <40% 2
Mean SVS/ISCVS comorbidity scoreb 12.8 6 6.3
Medication history
Antiplatelet therapy 10
b-blocker therapy 4
Statin therapy 3
COPD, Chronic obstructive pulmonary disease; Ef, ejection fraction;
ISCVS, International Society for Cardiovascular Surgery; SVS, Society for
Vascular Surgery; SD, standard deviation.
aEstimated glomerular ﬁltration rate <50.
bSVS reporting standards.22
Table II. Preoperative anatomy, prior aortic related
procedures, and clinical presentation
TAAA extenta N ¼ 16
II 1
III 4
IV 5
Suprarenal 5
Juxtarenal 1
Mean aneurysm size, cm 7.5 6 1.9
Prior aortic operations 9
TEVAR/EVAR 3
TAA/TAAA 2
Asc/Arch 2
Hybrid (debranching/TEVAR) 1
Open AAA 1
Operative indication
Urgent/symptomatic 9
Rupture 7
Asc/Arch, Ascending or transverse arch repair; EVAR, endovascular aneu-
rysm repair; TAA, thoracic aortic aneurysm; TAAA, thoracoabdominal
aortic aneurysm; TEVAR, thoracic aortic endograft repair.
aCrawford thoracoabdominal aneurysm extent.23
Table III. Branch vessel and graft modiﬁcation
characteristics
Branch vessels revascularized N ¼ 40a
Celiac artery 10
Superior mesenteric artery 10
Right renal artery 10
Left renal artery 10
Type of graft modiﬁcation
Fenestration branches 33
Directional graft branches 6
Permanent diameter reducing ties 2
Graft scallop 1
Stent ring excision 1
aForty-four total vessels were intended to be revascularized; however, one
patient required open surgical conversion with an attempted four-vessel
surgeon-modiﬁed endograft.
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standard deviation], 68 6 10 years; 88% male [n ¼ 14])
were treated with sm-EVAR for acute visceral aortic
pathology. All patients remained stable perioperatively, and
no procedures were abandoned due to hemodynamic
lability. Patient demographics, comorbidities, and preop-
erative medication history are shown in Table I. The mean
SVS comorbidity severity score25,26 was 12.8 6 6.3 ($8
considered high medical risk28).
Anatomic extent of disease is depicted in Table II.
Mean aneurysm diameter was 7.5 6 1.9 cm, and indica-
tions included a variety of suprarenal or thoracoabdominal
aortic pathologies as follows: mycotic paravisceral aneurysm
(four), symptomatic and/or ruptured juxta/suprarenal
aneurysm (six), or symptomatic and/or ruptured degener-
ative thoracoabdominal aneurysm (six), and all patients
were American Society of Anesthesiologists class IV (n ¼
9) or IV-E (n ¼ 7). The majority of patients (56%; n ¼
9) had undergone previous open or endovascular aortic
repair at a preoperative median time of 24.1 months
(range, 1-71). Three patients had undergone prior TEVAR
or EVAR and presented with type Ia/b endoleak.
Operative characteristics and branch vessel data.
Details of the branch vessels and speciﬁc types of device
modiﬁcations are outlined in Table III. Technical success
for endograft implantation and branch vessel revasculari-
zation was 94% (n ¼ 15/16). There were a total of 44
intended target branch vessels with 40 successfully revas-
cularized (91%) including 10 celiac arteries, 10 superior
mesenteric arteries, 10 right renal arteries, and 10 left renal
arteries. One patient accounted for all four failed revascu-
larizations and required conversion to a hybrid debranch-
ing procedure, described in detail below.
All procedures were completed under general anesthesia,
and preoperative spinal drainage was used in eight (50%)cases. Main body device TX-2 stent graft diameter compo-
nents ranged from 28-42 mm (28-34 mm, n ¼ 7; 36-42
mm, n ¼ 9) and four patients required iliac angioplasty
and stent graft placement to facilitate endograft delivery.
One patient failed percutaneous access and required an ilio-
femoral endarterectomy and patch angioplasty.
Median contrast use was 126 mL (range, 41-245), and
median ﬂuoroscopy and procedure times were 70 (range,
18-200) and 240 minutes (range, 134-900), respectively.
Comparison of urgent-symptomatic and emergent-
ruptured procedures is demonstrated in Table IV, with
signiﬁcant differences noted in time from admission to
the operating room, as well as ﬂuoroscopy and contrast
exposure. Endoleaks were identiﬁed intraoperatively in
three patients (type II, n ¼ 2; type IV, n ¼ 1), with
none of these requiring remediation to date.
Postoperative outcomes. Mean length of stay was
12 6 15 days (median, 5.5; range, 3-59). The majority
(63%; n ¼ 10) of patients were discharged home or to
Table IV. Operative characteristics for urgent-
symptomatic and emergent-ruptured indications of
suprarenal and thoracoabdominal acute aortic pathology
treated with surgeon-modiﬁed fenestrated endografts
Variable
Mean 6 SD or No. (%)
P valuea
Urg-Symp
(n ¼9)
Emer-Rupt
(n ¼7)
Time admission to OR,
hours
28 6 11 12 6 9 .008
Cerebrospinal ﬂuid drain 6 2 .3
OR time, minutes 373 6 225 217 6 86 .1
Fluoroscopy time, minutes 104 6 50 50 6 23 .02
Estimated blood loss, mL 617 6 900 229 6 57 .3
Crystalloid, liters 2.0 6 1.2 1.6 6 0.8 .5
Colloid, mL 388 6 253 321 6 345 .7
Packed red blood cells, units 1.3 6 1.5 0.7 6 1.2 .4
Contrast exposure, mL 148 6 49 98 6 39 .05
Emer-Rupt, Emergent-ruptured; OR, operating room; SD, standard devi-
ation; Urg-Symp, urgent-symptomatic.
This table demonstrates operative data for urgent vs emergent indications.
Not surprisingly, there was a signiﬁcantly longer admission to repair time in
the urgent vs emergent patients.
aP value determined using unpaired t-test and Fischer exact test when
applicable.
Table V. Postoperative outcomes and complicationsa
Feature N ¼ 16
Length of stay (median), days 5.5
In-hospital deathd 1
Any complication 6
Open conversion 1
Brachial sheath hematoma (return to OR) 1
Retroperitoneal hematoma (return OR) 1
Stroke (OR for PMT b) 1
Iliac dissection (return to OR)d 1
Urinary retention 2
Respiratory failured 2
Renal failure
Without hemodialysisc 2
Hemodialysis-dependentd 1
Spinal cord ischemia (permanent)d 1
Multiorgan failured 1
Colonic ischemiad 1
Any cardiac complication 0
OR, Operating room; PMT, pharmacomechanical thrombectomy.
aMultiple complications occurred with individual patients.
bPMT on postoperative day 0.
cDeﬁned as a 25% decrease in estimated glomerular ﬁltration rate.
dThese series of complications occurred in a single patient.
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one patient required transfer to a long-term acute care
facility. There were no 30-day postoperative deaths, but
one patient died during hospitalization 1.2 months (post-
operative day 38) after repair because of multisystem organ
failure (in-hospital mortality 6.3%). Table V outlines the
various complications that occurred. Six patients (38%;
urgent-symptomatic, n ¼ 2; emergent-ruptured, n ¼ 4)
had a postoperative complication with one person
suffering multiple complications.
One conversion to a hybrid repair was required while
attempting a four-vessel branched repair of a symptomatic,
degenerative type III TAAA. Because of severe aortic
tortuosity, the endograft was inadvertently deformed
during placement of a contralateral femoral sheath, effec-
tively closing the branches and making catheterization
impossible, and attempts at endovascular salvage were
unsuccessful. Of note, the endograft deformation resulted
in no visceral or renal malperfusion and did not complicate
the hybrid repair. The patient had a prolonged intensive
care unit stay complicated by respiratory failure and ulti-
mately was discharged to a long-term acute care setting.
The patient who died in-hospital had a symptomatic
TAAA associated with a Debakey type IIIb dissection and
an SVS comorbidity score of 23. The procedure required
a three-vessel fenestration to revascularize his visceral aortic
segment, re-expand his true lumen, and seal off a large fenes-
tration in this region of the aorta. Although the aneurysm
was repaired successfully, the patient developed multiple
complications including spinal cord ischemia, left colon
ischemia, multisystem organ failure (including respiratory
and hemodialysis-dependent renal failure), and eventually
care was withdrawn by the family on postoperative day 38.Follow-up and reintervention. At a median clinical
follow-up time of 6.2 (range, 1.2-16.1) months, one
patient required reintervention for a type III endoleak at
a superior mesenteric artery branch graft. This was
successfully treated with repeat angioplasty and stent graft
extension. Postoperative CTA was available for all patients
and demonstrated 100% branch vessel patency. There were
no migrations, component separations, fractures, or aneu-
rysm ruptures. For cases of mycotic aneurysm presenta-
tions, blood culture positivity was conﬁrmed in three of
four cases (Serratia, E coli, S aureus), and all four patients
were treated with 6 weeks of broad-spectrum intravenous
antibiotics and then species-speciﬁc oral suppressive anti-
biotics for life.
Six patients have reached $6 months of follow-up and
have imaging available for review. Of these six, aneurysm
diameter reduction ($5 mm) was noted in ﬁve of six
(83%). Three patients had complete aortic remodeling
around the stent graft (Fig 3) and one has a signiﬁcant
type III endoleak at the site of a superior mesenteric artery
fenestration now pending endovascular reintervention
(Table VI, online only, highlights individual patient
outcomes for renal function and aneurysm diameter over
the follow-up interval). Estimated 12-month survival after
sm-EVAR for AAS is 88 6 0.08% (Fig 4). There were
two late deaths (separate from the previously described
in-hospital death) at 1.4 and 13.4 months because of non-
aortic related pathology (pneumonia resulting in respira-
tory failure and myocardial infarction).
DISCUSSION
Although this is a highly selected series of patients, this
report demonstrates that branched and fenestrated endog-
rafts can be used in urgent or emergent settings with a high
Fig 3. Top panels, Preoperative and postoperative images of a patient with a ruptured pseudoaneurysm adjacent to the
visceral vessels 4 weeks after an open Extent IV thoracoabdominal aortic aneurysm (TAAA) repair at an outside
institution. A-C, Preoperative computed tomography (CT) demonstrating a large pseudoaneurysm. D, Three-
dimensional reconstruction demonstrating the same, with the white arrows in C and D demonstrating the opaciﬁed
blush within the pseudoaneurysm. E and F, Corresponding postoperative images at 15 months after repair, which
demonstrate complete resolution of the pseudoaneurysm and healing around the stent graft.
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complex visceral aortic pathology. Despite these patients
being deemed prohibitively high medical/anatomic risk
for open repair, a majority not only survived but were dis-
charged without major morbidity.
Aneurysms involving the visceral segment of the aorta
present a challenging clinical scenario, especially in the acutesetting in high-risk patients. Historically, patients managed
with intact TAAAs have been reported to have 10%-25%
perioperative mortality.9,34 Despite some improvement in
outcomes with elective operations attributable to advance-
ments in anesthesia, operative techniques, anduseof a variety
of adjuncts to minimize postoperative morbidity,35 these
results have not translated into the acute setting. Emergent
Fig 4. This graph demonstrates 12-month survival after surgeon-
modiﬁed endovascular aneurysm repair (sm-EVAR), which was
88%. One patient died during hospitalization after multiple
complications following repair, and two patients died of
nonaneurysm-related conditions at 1.4 and 13.4 months after
repair.
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in excess of 50%.8,36,37 Because of these poor results,
surgeons have sought other methods of repair in high-risk
patients, such as hybrid debranching procedures. Despite
the initial enthusiasm, these techniques have not consistently
delivered better outcomes, and many continue to advocate
conventional open repair.38-40 Indeed, because of these
reports and our own sobering results, we have largely aban-
doned the use of hybrid visceral debranching as a method to
treat high-risk patients.
Although our series is a highly selected patient popula-
tion given their hemodynamic stability at presentation, they
have multiple medical and anatomic factors that make them
high risk. This is evidenced by the patients’ preoperative
SVS comorbidity scores, the fact that many had undergone
previous open repair, and that all were believed to be
prohibitively high risk by a group of experienced surgeons
at a tertiary care medical center with a practice that collec-
tively treats approximately 600 aortic patients per year.
Notably, seven of our patients in this series had ruptured
thoracoabdominal aortic pathology, and six of these seven
(85%) not only survived repair, but were discharged to
home or a short-term rehabilitation facility. Despite these
promising results, we emphasize that because of the ques-
tionable durability of modiﬁed stent grafts, we continue to
offer open repair to those patients who are not believed to
be prohibitively high risk.
It is anticipated that as fenestrated/branched endograft
technology continues to develop, and “off-the-shelf”
devices become available, surgeons will be able to treat
even good-risk patients with symptomatic or ruptured
suprarenal and thoracoabdominal aneurysms. Our results
demonstrate that these technologies may provide an excel-
lent alternative to emergent open repair in the future. This
correlates well with the literature that has emergedregarding endovascular management of aortic emergencies
involving the infrarenal and descending thoracic aorta.37,41
Unfortunately, widespread nontrial availability of these
devices is years away, and even with adoption of this tech-
nology, there will continue to be patients whose anatomy
precludes endovascular repair.
Historically, necessity has encouraged surgeons to
develop innovative techniques for treatment of their
patients, andmany of thesemethodswere initially developed
without Food and Drug Administration (FDA) oversight.
Examples of this span surgical history and include the treat-
ment of emergent aortic disease by Drs Vorhees and Blake-
more with an aortic graft crafted on a sewing machine to
treat a ruptured aneurysm.42 More recently, Parodi and
colleagues,43 fashioned “homemade” endovascular devices
for the treatment of infrarenal aneurysms.43-45 Further
examples include the use of “chimney” and “snorkel” tech-
niques to treat aneurysms involving the visceral aorta,14,46,47
as well as the modiﬁcation of commercially available
devices.31,45 These novel strategies offer promising solutions
for high-risk patients with complex aortic pathology;
however, the modular nature of the fenestrated strategies
lends itself to intercomponent (eg, type III) endoleak,
whereas the various snorkel or chimney techniques are at
risk of perigraft “gutter” (eg, type I) leak. Given these limi-
tations, we do not advocate the widespread use of these off-
label techniques outside of an FDA-approved trial with an
investigational device exemption. However, one can easily
imagine various scenarios where patients may beneﬁt from
the use of off-label techniques, especially in emergent situa-
tions where patients are deemed “no option” or prohibi-
tively high open surgical risk. Patients and/or their
families in our series were all thoroughly informed of the
off-label nature of the repair, and the surgeon took full
responsibility for the success or failure of the operation.
There are several important limitations to this study
including the fact that this effectively represents an
extended case series of a small clinically and anatomically
heterogeneous group of patients. Also, this is essentially
a single-surgeon, single-center experience, and the results
cannot universally be applied. The extensive endovascular
experience, inventory, and postoperative ancillary support
required to successfully treat these patients are unlikely to
be reproducible in many centers. The signiﬁcant risk of
type II error, as well as potential overenthusiasm engen-
dered for graft modiﬁcation cannot be overstated. The
focus of this report is to detail the outcomes of a complex
group of patients managed urgently with complex endo-
vascular techniques. The selection bias introduced by
procedural planning, methods for intraoperative graft
construction, and implantation techniques selects for
hemodynamically stable patients, which undoubtedly
facilitates the promising results in this study and further
limits procedural applicability. This study was completed
without an FDA-approved investigational device exemp-
tion for graft modiﬁcation; however, the evolution in
practice and different types of unique graft modiﬁcations
(eg, using fenestration, temporary, and permanent
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same device) required to complete repair in a diverse
group of aortic pathologies with variable presentations
would not necessarily be possible within the constraints
of this type of mandate. Despite these limitations, we
believe that our results demonstrate that these techniques
can be applied selectively with acceptable outcomes.
In conclusion, fenestrated/branched endograft repair
can be safely performed for a variety of acute perivisceral
aortic conditions. Longer follow-up and greater patient
numbers are needed to determine durability and guide
application of these techniques.
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Table VI (online only). Change in renal function and
aortic diameter after surgeon-modiﬁed fenestrated
endovascular repair for acute visceral aortic pathology
Patient
Clinical
follow-up
time, months eGFR change
Change aneurysm
diameter
1 13.5 L9 L30
2 4.5 0 2
3 6.9 0 31
4 14.6 0 4
5 6.2 0 1
6 0.2 33 NA
7 2.1 0 2
8 1.4 0 NA
9 16.1 7 68
10 4.8 0 22
11 8.7 7 4
12 13.1 22 8
13 2.0 0 NA
14 1.2 L26 NA
15 1.8 0 NA
16 1.1 0 NA
eGFR, Estimated glomerular ﬁltration rate; NA, not available; SD, stan-
dard deviation.
Only 10 patients had contrasted imaging beyond 6 months postoperatively;
Patients highlighted in bold are ones that died; if patients who survived to
discharge are analyzed, the average decrease in eGFR after sm-FEVAR for
acute visceral aortic pathology was 5.2 6 9.8 mL/min/1.73 m2. For all
patients, the mean 6 SD decrease in maximal aortic diameter change was
17 6 21 mm.
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